Aligos Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ALGS, updated each market day.
ALGS AI Sentiment
AI sees no strong directional signal for Aligos Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Sector
Exchange
Market Cap
$49,131,187
Cap Tier
Employees
82
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
Oct. 16, 2020
Website
ALGS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ALGS Volatility
Aligos Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
